RODI NK™

RODI NK™
Product Description

Revolutionary Approach to Pregnancy's Greatest Challenge First-in-Class, FIrst -to -Market, Patented technology RODI NK™ addresses "The Immunological Paradox of Pregnancy" - the delicate balance between immune protection and embryo tolerance during the critical first trimester. Specifically formulated to maintain immune equilibrium during pregnancy's most vulnerable phase, preventing immune system hyperactivity that may lead to miscarriages. This breakthrough formulation is 100% plant-derived, vegetarian, and free from artificial colors and GMOs. Scientifically proven to support normal immune system function during early pregnancy, RODI NK™ is recommended for women during the first three months of pregnancy to maintain the critical immune balance that allows embryo tolerance while preserving maternal protection.

RODI FERTILITY

  • Country/Region:
    Cyprus
  • On CPHI since:
    2025
  • Certificates:
    3
  • Employees:
    1 - 24
Company types
Biopharmaceutical company
Start-up
Primary activities
Biopharmaceutical
Specifications
  • Details
    Gynecology, Fertillity, Woman Health
  • Selling Points
    Brand Name
  • Model
    Oral Liquid
  • Supplied from
    Italy
  • Measured In
    milligram

RODI FERTILITY

  • Country/Region:
    Cyprus
  • On CPHI since:
    2025
  • Certificates:
    3
  • Employees:
    1 - 24
Company types
Biopharmaceutical company
Start-up
Primary activities
Biopharmaceutical

More Products from RODI FERTILITY (2)

RODI FERTILITY resources (2)

  • News RODI Fertility: Revolutionizing Reproductive Medicine with Immune-Based Solutions

    RODI Fertility was created to address one of the most persistent gaps in reproductive medicine: women who experience miscarriage, implantation failure, or repeated IVF failure despite “normal” findings. Led by Dr. Barbara Geladakis, RODI pioneered an immune-based approach that reframes fertility care through the lens of reproductive immunology—bringing science, clinical insight, and compassion into one protocol-driven solution.